EOLS

Evolus, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$322.40 sample

+4.29 (+1.35%) 1D

Market cap

$1.66T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-18

Alerts

8

Price$322.40 +11.15% 3M daily closessample

328.26287.66

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: Chief Financial Officer
Oct 02INSInsider buy: Director
Sep 25INSInsider sell: General Counsel
Sep 18SECForm 144 filed
Sep 14SECDEF 14A filed
Sep 04SEC10-Q filed
Sep 01INSInsider sell: EVP, Operations
Aug 24INSInsider sell: EVP, Operations

Sign up to see the real EOLS record →

Company facts

SEC EDGAR registration

Name: Evolus, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +34sample, -100 to +100
Reporting currency: USD

Who is positioning in EOLS

sample

Insiders: 31 insider transactions over 90 days, net selling, $304.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 30 funds hold $16.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$82.2B +17.4% y/y

Q4 2024Q3 2026

Inventory$50.8B +17.1% y/y

Q4 2024Q3 2026

Accounts receivable$35.7B +6.5% y/y

Q4 2024Q3 2026

Total debt$98.3B +12.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $719.0B -11.1% 3M
Sample peer B: $734.7B -10.6% 3M
Sample peer C: $1.22T +13.4% 3M
Sample peer D: $619.3B +15.7% 3M
Sample peer E: $356.6B -10.2% 3M